These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12883737)

  • 21. Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma.
    Brasso K; Christensen IJ; Johansen JS; Teisner B; Garnero P; Price PA; Iversen P
    Prostate; 2006 Apr; 66(5):503-13. PubMed ID: 16372331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer.
    Johansen JS; Cintin C; Jørgensen M; Kamby C; Price PA
    Eur J Cancer; 1995; 31A(9):1437-42. PubMed ID: 7577068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer.
    Kim SH; Das K; Noreen S; Coffman F; Hameed M
    World J Surg Oncol; 2007 Feb; 5():17. PubMed ID: 17286869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and clinical significance of YKL-40 protein in epithelial ovarian cancer tissues.
    Yang GF; Cai PY; Li XM; Deng HX; He WP; Xie D
    Ai Zheng; 2009 Feb; 28(2):142-5. PubMed ID: 19550125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia.
    Kucur M; Isman FK; Balci C; Onal B; Hacibekiroglu M; Ozkan F; Ozkan A
    Urol Oncol; 2008; 26(1):47-52. PubMed ID: 18190830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells.
    Mylin AK; Rasmussen T; Johansen JS; Knudsen LM; Nørgaard PH; Lenhoff S; Dahl IM; Johnsen HE;
    Eur J Haematol; 2006 Nov; 77(5):416-24. PubMed ID: 16930142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease.
    Kronborg G; Ostergaard C; Weis N; Nielsen H; Obel N; Pedersen SS; Price PA; Johansen JS
    Scand J Infect Dis; 2002; 34(5):323-6. PubMed ID: 12069012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival.
    Johansen JS; Brasso K; Iversen P; Teisner B; Garnero P; Price PA; Christensen IJ
    Clin Cancer Res; 2007 Jun; 13(11):3244-9. PubMed ID: 17545529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum YKL-40, a new prognostic biomarker in cancer patients?
    Johansen JS; Jensen BV; Roslind A; Nielsen D; Price PA
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):194-202. PubMed ID: 16492905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic and prognostic value of serum YKL-40 in endometrial cancer.
    Fan JT; Si XH; Liao Y; Shen P
    Arch Gynecol Obstet; 2013 Jan; 287(1):111-5. PubMed ID: 22945838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer.
    Bi J; Lau SH; Lv ZL; Xie D; Li W; Lai YR; Zhong JM; Wu HQ; Su Q; He YL; Zhan WH; Wen JM; Guan XY
    Hum Pathol; 2009 Dec; 40(12):1790-7. PubMed ID: 19765801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma YKL-40: a potential new cancer biomarker?
    Johansen JS; Schultz NA; Jensen BV
    Future Oncol; 2009 Sep; 5(7):1065-82. PubMed ID: 19792974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population.
    Johansen JS; Bojesen SE; Mylin AK; Frikke-Schmidt R; Price PA; Nordestgaard BG
    J Clin Oncol; 2009 Feb; 27(4):572-8. PubMed ID: 19075264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating YKL-40 levels during human endotoxaemia.
    Johansen JS; Krabbe KS; Møller K; Pedersen BK
    Clin Exp Immunol; 2005 May; 140(2):343-8. PubMed ID: 15807860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects.
    Johansen JS; Lottenburger T; Nielsen HJ; Jensen JE; Svendsen MN; Kollerup G; Christensen IJ
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2603-8. PubMed ID: 18843001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The importance of determining the prognostic marker YKL-40 in serum and tissues].
    Łata E; Gisterek I; Matkowski R; Szelachowska J; Kornafel J
    Pol Merkur Lekarski; 2010 Jun; 28(168):505-8. PubMed ID: 20642115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and predictive value of YKL-40 in stage IIB-III melanoma.
    Krogh M; Christensen I; Bouwhuis M; Johansen JS; Nørgaard P; Schmidt H; Hansson J; Suciu S; Eggermont AM; Bastholt L;
    Melanoma Res; 2016 Aug; 26(4):367-76. PubMed ID: 27076041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma YKL-40 levels in healthy subjects from the general population.
    Bojesen SE; Johansen JS; Nordestgaard BG
    Clin Chim Acta; 2011 Apr; 412(9-10):709-12. PubMed ID: 21272568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.
    Nordenbaek C; Johansen JS; Halberg P; Wiik A; Garbarsch C; Ullman S; Price PA; Jacobsen S
    Scand J Rheumatol; 2005; 34(4):293-7. PubMed ID: 16195162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum YKL-40 levels in patients with coronary artery disease.
    Kucur M; Isman FK; Karadag B; Vural VA; Tavsanoglu S
    Coron Artery Dis; 2007 Aug; 18(5):391-6. PubMed ID: 17627189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.